enVVeno Medical (NVNO) Selling, General & Administrative (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 349.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 351.80 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 4.16 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | 3.30 Mn |
| Sep 30, 2023 | 2.55 Mn |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.91 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 7.21 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 1.88 Mn |
| Sep 30, 2020 | 1.16 Mn |
| Jun 30, 2020 | 839,735.00 |
| Mar 31, 2020 | 997,896.00 |
| Dec 31, 2019 | 922,339.00 |
| Sep 30, 2019 | 1.16 Mn |
| Jun 30, 2019 | 1.53 Mn |
| Mar 31, 2019 | 1.30 Mn |
| Dec 31, 2018 | 1.22 Mn |
| Sep 30, 2018 | 1.10 Mn |
| Jun 30, 2018 | 2.91 Mn |
| Mar 31, 2018 | 1.25 Mn |
| Dec 31, 2017 | 1.66 Mn |
| Sep 30, 2017 | 1.66 Mn |
| Jun 30, 2017 | 1.09 Mn |